Radiopharmaceuticals: all 1,299 studies that test it
Page 11 of 13. Open to participants first (296), then studies with results posted, then the rest; newest registration first within each.
- Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot StudyCompletedNCT02678884Not applicable
- Determining Oral Phosphate Tolerance Across the Spectrum of Glomerular Filtration RateCompletedNCT02672293Not applicable
- Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian OriginWithdrawnNCT02667925Not applicable
- Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid LeukemiaActive, not recruitingNCT02665065Phase 3
- PET/MRI in Patients With Suspected Prostate CancerCompletedNCT02659527Phase 3
- Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)WithdrawnNCT02657447Phase 1
- Selenium Supplementation in Youths With Autoimmune ThyroiditisCompletedNCT02644707Phase 4
- Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CTActive, not recruitingNCT02637934Phase 1
- Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate CancerCompletedNCT02615067Phase 3
- Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion ImagingWithdrawnNCT02608944Not applicable
- Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple MyelomaWithdrawnNCT02605356Phase 1/2
- 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer PatientsTerminatedNCT02602067Phase 1
- Investigating the Microstructural and Functional Alterations of Brain in Parkinson's Disease PatientsCompletedNCT02599753Phase 2
- 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of NesidioblastosisStatus unknownNCT02560376Early Phase 1
- PV-10 in Combination With Pembrolizumab for Treatment of Metastatic MelanomaActive, not recruitingNCT02557321Phase 1/2
- Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With TauopathiesCompletedNCT02531360Early Phase 1
- 18F-AV-1451 PET Imaging in TBIWithdrawnNCT02512029Phase 1
- A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 PlaceboWithdrawnNCT02496832Not applicable
- Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEBStatus unknownNCT02496013Phase 1
- Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in Advanced Gastro-entero Pancreatic Neuroendocrine TumorsTerminatedNCT02489604Phase 2
- Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell LymphomasTerminatedNCT02488512Phase 2
- Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT)Status unknownNCT02484339Phase 2
- PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate CancerTerminatedNCT02483884Phase 1/2
- Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone LesionsCompletedNCT02442063Phase 1
- NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate CancerTerminatedNCT02429804Phase 1
- Artificial Oocyte Activation Comparing Tow Different AgentsCompletedNCT02424214Not applicable
- Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid CancerStatus unknownNCT02418247Phase 2/3
- FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine TherapyActive, not recruitingNCT02398773Phase 2
- Gallium-68 Citrate PET Used in Prostate CancerCompletedNCT02391025Early Phase 1
- 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or TransplantActive, not recruitingNCT02379377Phase 1
- MIBG Therapy for Patients With MIBG Avid TumorsActive, not recruitingNCT02378428Phase 2
- 18F-FES PET/CT in Imaging Patients With Desmoid TumorsTerminatedNCT02374931Early Phase 1
- PET Imaging of Intracranial Cancers With 18F-FSPGTerminatedNCT02370563Phase 1
- Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's DiseaseCompletedNCT02370524Phase 1
- Investigating the Clinical Consequences of Flutemetamol-PET-scanningTerminatedNCT02353949Phase 3
- Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin LymphomaCompletedNCT02342782Phase 1
- Tc99m Sestamibi Molecular Breast ImagingActive, not recruitingNCT02324387Not applicable
- A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10CompletedNCT02322086Phase 2
- PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot StudyActive, not recruitingNCT02307630Not applicable
- Study of Tumor Metabolism by Isotopic Tagging in Patients With High-grade Glioma (CARBONOMIC)TerminatedNCT02305056Phase 1
- Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AITStatus unknownNCT02302768Phase 2
- Pretargeted Radioimmunotherapy in Metastatic Colorectal CancerTerminatedNCT02300922Phase 1/2
- [18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast CancerActive, not recruitingNCT02284919Phase 1
- 68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate CancerStatus unknownNCT02282137Phase 2
- Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT02278315Phase 1
- Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic ImpairmentCompletedNCT02259855Phase 1
- Pharmacokinetic Interaction Between Tipranavir and BILR 355 BS Plus Ritonavir in Healthy Male VolunteersCompletedNCT02257021Phase 1
- Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult VolunteersCompletedNCT02253875Phase 1
- Pharmacokinetic of Tadalafil Co-administered With Tipranavir/Ritonavir to Healthy Male VolunteersCompletedNCT02253862Phase 1
- Pharmacokinetic Study in Healthy Adult Volunteers to Assess the Interactions Between Steady-State Tipranavir and Atazanavir in the Presence of RitonavirCompletedNCT02253836Phase 1
- Pharmacokinetics of Tipranavir/Ritonavir and Its Metabolites in Healthy Male SubjectsCompletedNCT02253797Phase 1
- Effects of Steady State Tipranavir/Ritonavir or Darunavir/Ritonavir or Ritonavir on Platelet Function, Coagulation and Fibrinolysis Biomarkers in Healthy SubjectsCompletedNCT02251795Phase 1
- Effects of Single-dose and Steady-state TPV/r on the Steady-state Pharmacokinetics of Clarithromycin and a Preliminary Assessment of the Effects of a Standard High-fat Test Meal on the Steady-state Pharmacokinetics of TipranavirCompletedNCT02251769Phase 1
- Bioavailability of Tipranavir/Ritonavir Paediatric Solution Compared to Tipranavir/Ritonavir Capsules in Healthy Female and Male SubjectsCompletedNCT02251158Phase 1
- The Pharmacodynamic/Pharmacokinetic Interaction of Tipranavir and Ritonavir With Loperamide in Healthy VolunteersCompletedNCT02251119Phase 1
- Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic InsufficiencyCompletedNCT02249442Phase 1
- Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without TipranavirCompletedNCT02249130Phase 2
- Study of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Methadone Administered in Healthy VolunteersCompletedNCT02245451Phase 1
- Pharmacokinetics of Atorvastatin With Tipranavir/Ritonavir and the Effect of Antacid on the Pharmacokinetics of Single-Dose Tipranavir/Ritonavir in Healthy VolunteersCompletedNCT02245269Phase 1
- Bioequivalence of Two Different Oral Solutions Tipranavir Administered in Combination With Ritonavir to Healthy VolunteersCompletedNCT02244190Phase 1
- Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy VolunteersCompletedNCT02243553Phase 1
- Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase IICompletedNCT02230176Phase 2
- Effect of Steady State TPV/r on Intracellular Concentrations of Zidovudine and Carbovir for Patients With HIVTerminatedNCT02229760Phase 1/2
- Effects of Steady-state Efavirenz 600 mg QD (Sustiva®) on Tipranavir Concentration at Steady-state in Healthy Adult VolunteersCompletedNCT02226991Phase 1
- Pharmacokinetic Interaction Study of Steady-state Tipranavir/Ritonavir (TPV/r) With Single-dose Valaciclovir (VAL) in Healthy VolunteersCompletedNCT02226978Phase 1
- Effects of Single-dose and Steady-state TPV/RTV on the Steady-state Pharmacokinetics of Fluconazole in Healthy Adult VolunteersCompletedNCT02195466Phase 1
- 18F-DTBZ PET and Multi-modal MRI in the Patients With Vascular ParkinsonismCompletedNCT02195154Phase 2
- Response Monitoring Trial in Patients With Suspected Recurrence of GlioblastomaTerminatedNCT02176720Phase 1
- Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate CancerCompletedNCT02151760Phase 1
- Effectiveness of a Homecare Dentin Hypersensitivity GelCompletedNCT02128633Phase 2/3
- Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy SubjectsCompletedNCT02103894Phase 1
- 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.Active, not recruitingNCT02088645Phase 1
- To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular CarcinomaStatus unknownNCT02074202Phase 3
- Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by SurgeryCompletedNCT02072356Early Phase 1
- Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-PlerixaforTerminatedNCT02069080Early Phase 1
- Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular LymphomaCompletedNCT02063685Phase 3
- Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and ParkinsonismCompletedNCT02059733Phase 2
- A Phase I Study of MLN6907 in Patients With Metastatic ColorectalCompletedNCT02056015Phase 1
- Imaging Non-motor Symptoms of Parkinson's Disease by Novel 18F-DTBZ and Florbetapir F-18 PETCompletedNCT02039024Phase 2
- Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese PhysiciansWithdrawnNCT02029547Not applicable
- 18F-DOPA-PET in Planning Surgery in Patients with GliomasCompletedNCT02020720Early Phase 1
- In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility StudyCompletedNCT01995084Not applicable
- 18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate CancerCompletedNCT01993160Not applicable
- Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)CompletedNCT01962753Not applicable
- C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progressionWithdrawnNCT01961934Phase 2/3
- Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic CancerTerminatedNCT01956812Phase 3
- 68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid ArthritisStatus unknownNCT01940926Early Phase 1
- FACBC for Head and Neck CancersWithdrawnNCT01933269Early Phase 1
- Japanese BAY88-8223 Monotherapy Phase II StudyCompletedNCT01929655Phase 2
- Phase I/IIA Study of PET Imaging With 89Zr-Df-IAB2M in Metastatic Prostate CancerCompletedNCT01923727Phase 1/2
- Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent GlioblastomaTerminatedNCT01898273Phase 2
- Evaluation of Hypoxia by PET With F-Miso in Radiation Therapy of Prostate CancerCompletedNCT01898065Phase 2
- Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative ChemotherapyCompletedNCT01894451Early Phase 1
- 68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)CompletedNCT01879657Not applicable
- A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine TumoursSuspendedNCT01876771Phase 2
- Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's PerspectiveCompletedNCT01873248Early Phase 1
- FMISO-PET in Brain Tumors and SCS EffectTerminatedNCT01868906Phase 2
- 123-I mIBG (AdreView) Heart-to-Mediastinal (H/M) Ratio and SPECT Imaging on a Small Field of View-High Efficiency Cardiac SPECT SystemCompletedNCT01868841Phase 4
- Randomized Phase III of PRRT Versus InterferonWithdrawnNCT01860742Phase 3
- 89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple MyelomaStatus unknownNCT01859234Not applicable